Salarius Pharmaceuticals Reports Third Quarter 2021 Financial Results and Highlights Recent Company ProgressGlobeNewsWire • 11/04/21
Will Salarius (SLRX) Report Negative Earnings Next Week? What You Should KnowZacks Investment Research • 10/28/21
Salarius Pharmaceuticals to Report Third Quarter 2021 Financial Results and Highlight Recent Company ProgressGlobeNewsWire • 10/26/21
Salarius Pharmaceuticals and Nationwide Children's Hospital Disclose Research Findings from Presentation at 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer TherapeuticsGlobeNewsWire • 10/07/21
Salarius Pharmaceuticals and Nationwide Children's Hospital Announce Poster Presentation at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer TherapeuticsGlobeNewsWire • 09/30/21
Salarius Pharmaceuticals Receives $2.7 Million in Payment from the Cancer Prevention and Research Institute of TexasGlobeNewsWire • 09/28/21
Salarius Pharmaceuticals and Fox Chase Cancer Center Launch Research PartnershipGlobeNewsWire • 09/22/21
Salarius Pharmaceuticals to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment ConferenceGlobeNewsWire • 09/08/21
Salarius Pharmaceuticals to Present at the Virtual Diamond Equity Research Emerging Growth InvitationalGlobeNewsWire • 08/12/21
Salarius Pharmaceuticals, Inc. (SLRX) CEO David Arthur on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/08/21
Salarius Pharmaceuticals Reports Second Quarter 2021 Financial Results and Highlights Recent Company ProgressGlobeNewsWire • 08/05/21
Salarius Pharmaceuticals Announces Aundrietta Duncan, Ph.D., To Present During Virtual Epigenetic Therapeutic Targets SummitGlobeNewsWire • 07/14/21
Salarius Pharmaceuticals Adds Fox Chase Cancer Center to Ongoing Trial of Seclidemstat as a Treatment for Ewing Sarcoma and FET-Rearranged SarcomasGlobeNewsWire • 07/13/21
Salarius Pharmaceuticals to Present at the Virtual Ladenburg Thalmann Healthcare ConferenceGlobeNewsWire • 07/09/21
REMINDER: Salarius Pharmaceuticals to Host Virtual Key Opinion Leader and Investor EventGlobeNewsWire • 06/17/21
Salarius Pharmaceuticals Announces New Clinical Trial to Study Seclidemstat in Hematologic CancersGlobeNewsWire • 06/15/21
Salarius Pharmaceuticals to Host Virtual Key Opinion Leader and Investor EventGlobeNewsWire • 06/10/21
Salarius' Seclidemstat Shows Single-Agent Drug Activity in Heavily Pre-Treated Sarcomas PatientsBenzinga • 06/07/21
Salarius Pharmaceuticals Presents New Research Data Demonstrating Seclidemstat's Safety, Dosing, and Drug Activity at American Society of Clinical Oncology (ASCO) 2021 Annual MeetingGlobeNewsWire • 06/07/21